Correlation Between ProPhase Labs and Enzo Biochem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ProPhase Labs and Enzo Biochem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProPhase Labs and Enzo Biochem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProPhase Labs and Enzo Biochem, you can compare the effects of market volatilities on ProPhase Labs and Enzo Biochem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProPhase Labs with a short position of Enzo Biochem. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProPhase Labs and Enzo Biochem.

Diversification Opportunities for ProPhase Labs and Enzo Biochem

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between ProPhase and Enzo is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding ProPhase Labs and Enzo Biochem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzo Biochem and ProPhase Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProPhase Labs are associated (or correlated) with Enzo Biochem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzo Biochem has no effect on the direction of ProPhase Labs i.e., ProPhase Labs and Enzo Biochem go up and down completely randomly.

Pair Corralation between ProPhase Labs and Enzo Biochem

Given the investment horizon of 90 days ProPhase Labs is expected to under-perform the Enzo Biochem. But the stock apears to be less risky and, when comparing its historical volatility, ProPhase Labs is 1.13 times less risky than Enzo Biochem. The stock trades about -0.09 of its potential returns per unit of risk. The Enzo Biochem is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  172.00  in Enzo Biochem on August 25, 2024 and sell it today you would lose (75.00) from holding Enzo Biochem or give up 43.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ProPhase Labs  vs.  Enzo Biochem

 Performance 
       Timeline  
ProPhase Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProPhase Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Enzo Biochem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enzo Biochem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Enzo Biochem is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

ProPhase Labs and Enzo Biochem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ProPhase Labs and Enzo Biochem

The main advantage of trading using opposite ProPhase Labs and Enzo Biochem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProPhase Labs position performs unexpectedly, Enzo Biochem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzo Biochem will offset losses from the drop in Enzo Biochem's long position.
The idea behind ProPhase Labs and Enzo Biochem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency